Natchimuthu Balashanmugam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Natchimuthu Balashanmugam has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Abd Elmoneim O. Elkhalifa
Department of Clinical Nutrition, College of Applied Medical Sciences, University of Ha’il, Hail P.O. Box 2440, Saudi Arabia
1 shared publication - Abdulwahab Alamri
Department of Pharmacology and Toxicology, College of Pharmacy, University of Ha’il, Ha’il 55476, Saudi Arabia
1 shared publication - Afrasim Moin
Department of Pharmaceutics, College of Pharmacy, University of Hail
1 shared publication - Ahmed Alafnan
Department of Pharmacology and Toxicology, College of Pharmacy, University of Ha’il, Ha’il, Saudi Arabia
1 shared publication - Amir Mahgoub Awadelkareem
Department of Clinical Nutrition, College of Applied Medical Sciences, University of Hail, Ha’il 81442, Saudi Arabia
1 shared publication - Aravindram Attiguppe Seetharam
Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSSAHER), Sri Shivarathreeshwara Nagar, Mysore 570015, India
1 shared publication
Latest Publications
- 17 May 2023
- Published by Springer Nature
- p. 137-147
Finishing of Laser Powder Bed Fusion-Based Turbine Blade Sample Using Polymer Rheological Abrasive Fluids
- 17 May 2023
- Published by Springer Nature
- p. 137-147
Finishing of Laser Powder Bed Fusion-Based Turbine Blade Sample Using Polymer Rheological Abrasive Fluids
- Open Access
Development and Characterization of PEGDA Microneedles for Localized Drug Delivery of Gemcitabine to Treat Inflammatory Breast Cancer
Inflammatory breast cancer (IBC) is one of the most belligerent types of breast cancer. While various modalities exist in managing/treating IBC, drug delivery using microneedles (MNs) is considered to be the most innovative method of localized delivery of anti-cancer agents. Localized drug delivery helps to treat IBC could limit their adverse reactions. MNs are nothing but small needle like structures that cause little or no pain at the site of administration for drug delivery via layers of the skin. The polyethylene glycol diacrylate (PEGDA) based MNs were fabricated by using three dimensional (3D) technology called Projection Micro-Stereo Lithography (PµSL). The fabricated microneedle patches (MNPs) were characterized and coated with a coating formulation comprising of gemcitabine and sodium carboxymethyl cellulose by a novel and inventive screen plate method. The drug coated MNPs were characterized by various instrumental methods of analysis and release profile studies were carried out using Franz diffusion cell. Coat-and-poke strategy was employed in administering the drug coated MNPs. Overall, the methods employed in the present study not only help in obtaining MNPs with accurate dimensions but also help in obtaining uniformly drug coated MNPs of gemcitabine for treatment of IBC. Most importantly, 100% drug release was achieved within the first one hour only.
Open AccessDevelopment and Characterization of PEGDA Microneedles for Localized Drug Delivery of Gemcitabine to Treat Inflammatory Breast Cancer
Inflammatory breast cancer (IBC) is one of the most belligerent types of breast cancer. While various modalities exist in managing/treating IBC, drug delivery using microneedles (MNs) is considered to be the most innovative method of localized delivery of anti-cancer agents. Localized drug delivery helps to treat IBC could limit their adverse reactions. MNs are nothing but small needle like structures that cause little or no pain at the site of administration for drug delivery via layers of the skin. The polyethylene glycol diacrylate (PEGDA) based MNs were fabricated by using three dimensional (3D) technology called Projection Micro-Stereo Lithography (PµSL). The fabricated microneedle patches (MNPs) were characterized and coated with a coating formulation comprising of gemcitabine and sodium carboxymethyl cellulose by a novel and inventive screen plate method. The drug coated MNPs were characterized by various instrumental methods of analysis and release profile studies were carried out using Franz diffusion cell. Coat-and-poke strategy was employed in administering the drug coated MNPs. Overall, the methods employed in the present study not only help in obtaining MNPs with accurate dimensions but also help in obtaining uniformly drug coated MNPs of gemcitabine for treatment of IBC. Most importantly, 100% drug release was achieved within the first one hour only.
- 13 September 2022
- Published by Springer Nature
- p. 213-224
Experimental Study on Cylindrical Grinding of Bearing Bush to Improve Surface Finish
- 13 September 2022
- Published by Springer Nature
- p. 213-224
Experimental Study on Cylindrical Grinding of Bearing Bush to Improve Surface Finish